OABI.NASDAQOmniab, INC

Form 4: OmniAb Director Philip J. Gotwals Reports Stock Transactions

Sentiment:

Insider Transaction Report


OmniAb, Inc. Director Philip J. Gotwals reported transactions involving common stock, restricted stock units, and stock options on June 17, 2026.

Summary

  • Philip J. Gotwals, a Director at OmniAb, Inc., reported several transactions on June 17, 2026.
  • These transactions include the vesting of 20,000 Restricted Stock Units (RSUs) and the acquisition of 20,000 additional RSUs.
  • Additionally, 40,000 stock options were acquired.
  • Following these transactions, Mr. Gotwals beneficially owns 33,333 shares of common stock directly, and a total of 46,667 RSUs and 40,000 stock options.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports routine insider transactions and does not provide performance metrics or strategic updates that would indicate a significant shift in sentiment.

Positives

  • Director Philip J. Gotwals received an additional grant of 20,000 RSUs.
  • Director Philip J. Gotwals acquired 40,000 stock options, indicating potential future equity participation.

Negatives

  • The filing does not explicitly detail any negative financial performance or events.

Risks

  • The vesting and exercise of stock options and RSUs are subject to specific conditions, including the date of the next annual stockholder meeting or the anniversary of the grant date, which could impact the timing of equity realization.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently reflect company performance. The reported transactions by Director Philip J. Gotwals are typical for executive compensation and incentive structures within the biotechnology sector, where OmniAb, Inc. operates.

Stakeholder Impact

  • Shareholders: The transactions reported do not directly impact current share price or company financials but reflect executive compensation and potential future dilution if options are exercised.

Next Steps

  • The vesting and exercise of RSUs and stock options are subject to specific conditions outlined in the grant agreements.

Key Dates

DateDescription
06/17/2025Grant date for RSUs and Stock Options (implied by vesting conditions).
06/17/2026Date of earliest transaction reported, including vesting of RSUs, acquisition of RSUs, and acquisition of stock options.
06/18/2026Date the Form 4 was signed by the attorney-in-fact.
06/17/2036Expiration date for stock options acquired on 06/17/2026.

Keywords

OmniAb Inc, OABI, Form 4, SEC Filing, Stock Transaction, Director, Philip J. Gotwals, Restricted Stock Units, Stock Options, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.